The Therapeutic Outcomes of Alcohol Withdrawal Syndrome Treatment for Inpatient at Hospitals Affiliated with Surin Hospital
Article Sidebar
Main Article Content
Abstract
Objective: To study the treatment outcomes of inpatients with alcohol withdrawal syndrome in Surin Hospital Network, including the amount of Diazepam received during inpatient treatment, and the duration of alcohol withdrawal symptoms.
Methods: A retrospective study of inpatient medical records from Surin Hospital Network between October 2022 - September 2023, with a total of 140 patients. Patient demographic data were analyzed using descriptive statistics. The median survival time was estimated using the Kaplan-Meier method and tested using the log-rank test.
Results: All patients were male, with a mean age of 40.58 ± 10.39 years. 75% were alcohol dependent. The most common complications were delirium (55%), hypokalemia (45.71%), hypomagnesemia (43.57%), and hepatitis (22.86%). The average duration of alcohol withdrawal was 3.27 ± 1.39 days. At the 5-day follow-up, 98 patients recovered from alcohol withdrawal, with a median recovery time of 4 days (95% CI: 4.0 - 5.0). The recovery time differed significantly according to symptom severity. The severe symptom group received the highest dose of Diazepam (195.14 ± 80.95 mg).
Conclusion: Most patients were alcohol dependent and had significant complications. The median duration of alcohol withdrawal was 4 days. The duration and amount of medication used were directly related to symptom severity. This information is useful for treatment planning, monitoring complications, and preparing resources for the care of patients with alcohol withdrawal syndrome.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles submitted for consideration must not have been previously published or accepted for publication in any other journal, and must not be under review by any other journal.
References
Bayard M, McIntyre J, Hill KR, Woodside J. Alcohol withdrawal syndrome. Am Fam Physician 2004;69(6):1443-50.
Lee JA, Duby JJ, Cocanour CS. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome. Clin Toxicol 2019;57(7):624-7.
National institute for drug abuse treatment and rehabilitation princess mother. Guidelines for the care of patients with alcohol withdrawal syndrome. Bangkok: Chulalongkorn University Printing House; 2015.
Klinpiboon A, Srison P, Fangkaew A. Results of improving and developing alcohol withdrawal assessment form, Prasrimahabhodi Hospital. Journal of Science and Technology 2013;15(3):30-42.
Suan Prung Hospital. Guidelines for the treatment of mental health problems from alcohol in the situation of the coronavirus disease 2019 epidemic. Chiang Mai: Department of Mental Health Ministry Of Public Health; 2021.
Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome. Cochrane Database Syst Rev 2011; 2011(6):CD008537.
Orser BA, Bertlik M, Wang LY, MacDonald JF. Inhibition by propofol (2, 6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br J Pharmacol 1995;116(2):1761.
Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. J Neurosurg Anesthesiol 2006;104(1):21-6.
Hammond DA, Rowe JM, Wong A, Wiley TL, Lee KC, Kane-Gill SL. Patient outcomes associated with phenobarbital use with or without benzodiazepines for alcohol withdrawal syndrome: a systematic review. Hosp Pharm 2017;52(9):607-16.
Ministry of public health. Accessibility to mental health service system [cited 2024 July 13]. Available from: https://srn.hdc.moph.go.th/hdc/reports/report.php?cat_id=ea11bc4bbf 333b78e6f53a26f7ab6c89&id=8a173a9de38de5c0172953d4ebcdcb09.
Faul F, Erdfelder E, Lang A-G, Buchner A. G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39(2):175-91.
Silpakit P, Kittiratanaphiabul P. Alcohol use disorders identification test: Practical guidelines for primary care settings. Tantawan Paper Co., Ltd: Integrated Alcohol Treatment System Development Project; 2009.
Sinclair M, McRee B, Babor T. Evaluation of the Reliability of AUDIT. University of Connecticut School of Medicine, Alcohol Research Center,(unpublished report) 1992.
Virojarurueang K, Silakul A, Charoenchai W. Development of guidelines for caring for alcohol patients during alcohol withdrawal in inpatients, Prasat Neurological Institute. J Somdet Chaopraya Inst Psychiat 2021;15(1):29-48.
Wiseman EJ, Henderson KL, Briggs MJ. Outcomes of patients in a VA ambulatory detoxification program. Psychiatr Serv 1997;48(2):200-3.
Pinthong J, Jongwutiwes S, Triprasertsouk S. Outcomes of implementing alcohol withdrawal syndrome care protocol at Srinagarind Hospital. J Psychiatr Assoc Thailand 2019;64(3):243-54.
Day E, Daly C. Clinical management of the alcohol withdrawal syndrome. Addiction 2022;117(3):804-14.
Lee JA, Duby JJ, Cocanour CS. Effect of early and focused benzodiazepine therapy on length of stay in severe alcohol withdrawal syndrome. Clin Toxicol (Phila) 2019;57(7):624-7.
Perry EC. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs 2014;28(5):401-10.
Brothers TD, Bach P. Challenges in prediction, diagnosis, and treatment of alcohol withdrawal in medically ill hospitalized patients: a teachable moment. JAMA Intern Med 2020;180(6):900-1.
Hack JB, Hoffman R, Nelson LS. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early?. J Med Toxicol 2006;2:55-60.
Psychiatric Association of Thailand. Clinical practice guidelines for alcohol withdrawal syndrome management. Bangkok: Psychiatric Association of Thailand; 2020.
Palmer BF, Clegg DJ. Electrolyte disturbances in patients with chronic alcohol-use disorder. N Engl J Med 2017;377(14):1368-77.
Anderson R, Cohen M, Haller R. Skeletal muscle phosphorus and magnesium deficiency in alcoholic myopathy. Miner Electrolyte Metab 1980;4(3):106-12.
Hundert S, Dunn AS. Inpatient Management of Alcohol Withdrawal: A Review. Can J Gen Intern Med 2024;19(1):52-62. doi:10.22374/cjgim.2023.0730.
Peterson BD, Stotts M. Beyond the banana bag: treating nutritional deficiencies of alcohol withdrawal syndrome. Pract Gastroenterol 2021;45(6):48-58.
